NCT01475123Active, not recruitingPhase 4
Prospective Study of End Stage Renal Disease Patients With Coronary Artery Disease Treated by Oral Nicorandil
Effects of Nicorandil on Cardiovascular Events in Patients With Coronary Artery Disease Receiving Hemodialysis
Source: ClinicalTrials.gov · Last updated 3 Sept 2026
Brief summary (registry, in English)
Nicorandil is potentially effective to prevent cardiovascular events in patients with coronary artery disease (CAD) receiving hemodialysis. The purpose of this study is to prospectively investigate whether nicorandil is effective in reducing the incidence of cardiovascular events in patients with CAD on hemodialysis.
- Status (registry)
- Active, not recruiting
- Phase (registry)
- Phase 4
- Study type
- Interventional
- Enrollment
- 268 (actual)
- First submitted
- 16 Nov 2011
- Start date
- Jun 2008
- Primary completion date
- Jun 2011
- Lead sponsor
- Kumamoto University
- NCT number
- NCT01475123
What you commit to
- Study type: Interventional · Phase 4
- Participants enrolled: 268
- From Jun 2008 to the primary completion date, Jun 2011
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Treatment with phosphodiesterase type 5 inhibitor
Other illness
- Within one month after acute myocardial infarction
- Severe disease requiring active medical treatment
Other
- Within 3 months after coronary artery bypass graft (CABG)
- Candidates for carotid artery stenting
Who the study is looking for
- Eligible patients are who meet the following criteria:
- Patient with previously diagnosed coronary artery disease (significant coronary artery stenosis is defined as \> 75% narrowing of the artery lumen)
- Patients who continued hemodialysis for more than one month
Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University Coordinator of this site? Confirm its status | Kumamoto | Japan | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.